SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Escalon Medical Corp – ‘10-Q’ for 3/31/19

On:  Tuesday, 5/14/19, at 4:24pm ET   ·   For:  3/31/19   ·   Accession #:  862668-19-7   ·   File #:  0-20127

Previous ‘10-Q’:  ‘10-Q’ on 2/14/19 for 12/31/18   ·   Next:  ‘10-Q’ on 11/14/19 for 9/30/19   ·   Latest:  ‘10-Q’ on 2/14/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/14/19  Escalon Medical Corp              10-Q        3/31/19   49:3.6M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    359K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
12: R1          Document And Entity Information                     HTML     35K 
13: R2          Consolidated Balance Sheets                         HTML    101K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     31K 
15: R4          Consolidated Statements Of Operations               HTML     70K 
16: R5          Consolidated Statements Of Shareholders' Equity     HTML     54K 
                and Comprehensive Loss                                           
17: R6          Consolidated Statements Of Cash Flows               HTML     88K 
18: R7          Organization and Description of Business            HTML     21K 
19: R8          Going concern (Notes)                               HTML     21K 
20: R9          Significant Accounting Policies                     HTML    111K 
21: R10         Inventory (Notes)                                   HTML     26K 
22: R11         Discontinued operation (Notes)                      HTML     55K 
23: R12         Related Party Transactions                          HTML     26K 
24: R13         Line of credit (Notes)                              HTML     27K 
25: R14         Commitments and Contingencies                       HTML     24K 
26: R15         Concentration of credit risk (Notes)                HTML     46K 
27: R16         Revenue from contracts with customers (Notes)       HTML     49K 
28: R17         Other income (Notes)                                HTML     18K 
29: R18         Significant Accounting Policies (Policies)          HTML    142K 
30: R19         Significant Accounting Policies (Tables)            HTML     68K 
31: R20         Inventory (Tables)                                  HTML     27K 
32: R21         Commitments and Contingencies (Tables)              HTML     23K 
33: R22         Concentration of credit risk (Tables)               HTML     72K 
34: R23         Significant Accounting Policies (Cash and Cash      HTML     21K 
                Equivalents) (Details)                                           
35: R24         Significant Accounting Policies (Accounts           HTML     17K 
                Receivable) (Details)                                            
36: R25         Significant Accounting Policies (Net Income (loss)  HTML     30K 
                Per Share) (Details)                                             
37: R26         Significant Accounting Policies Earning per share   HTML     57K 
                details (Details)                                                
38: R27         Inventory (Details)                                 HTML     25K 
39: R28         Discontinued operation (Details)                    HTML     34K 
40: R29         Related Party Transactions (Details)                HTML     45K 
41: R30         Line of credit (Details)                            HTML     77K 
42: R31         Commitments and Contingencies (Details)             HTML     34K 
43: R32         Concentration of credit risk (Details)              HTML     81K 
44: R33         Revenue from contracts with customers (Details)     HTML     25K 
45: R34         Other income (Details)                              HTML     16K 
46: R9999       Uncategorized Items - esmc-20190331.xml             HTML     14K 
48: XML         IDEA XML File -- Filing Summary                      XML     80K 
47: EXCEL       IDEA Workbook of Financial Reports                  XLSX     53K 
 6: EX-101.INS  XBRL Instance -- esmc-20190331                       XML    930K 
 8: EX-101.CAL  XBRL Calculations -- esmc-20190331_cal               XML    111K 
 9: EX-101.DEF  XBRL Definitions -- esmc-20190331_def                XML    387K 
10: EX-101.LAB  XBRL Labels -- esmc-20190331_lab                     XML    840K 
11: EX-101.PRE  XBRL Presentations -- esmc-20190331_pre              XML    525K 
 7: EX-101.SCH  XBRL Schema -- esmc-20190331                         XSD     87K 
49: ZIP         XBRL Zipped Folder -- 0000862668-19-000007-xbrl      Zip    126K 




        
Filing Submission 0000862668-19-000007 – SGML Text

Original SGML Text submitted by:  Escalon Medical Corp.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 5:56:26.2pm ET